• linkedin
  • Increase Font
  • Sharebar

    Top five treatment mainstays: Ulcerated pediatric hemangiomas

    Managing pain and complications


    Disclosures: Neither Dr. Lara-Corrales nor Dr. Puttgen report any relevant disclosures.




    1. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122(2):360-7.

    2. Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007;151(6):684-9, 689.e1.

    3. Maguiness SM, Hoffman WY, Mccalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146(11):1235-9.

    4. Yan AC. Pain management for ulcerated hemangiomas. Pediatr Dermatol. 2008;25(6):586-9.

    5. Metry D. Ten lessons learned from a hemangioma clinic, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884766/

    6. Mccuaig CC, Cohen L, Powell J, et al. Therapy of ulcerated hemangiomas. J Cutan Med Surg. 2013;17(4):233-42.

    7. Pope E, Chakkittakandiyil A, Lara-corrales I, Maki E, Weinstein M. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol. Br J Dermatol. 2013;168(1):222-4. 


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow